These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

543 related items for PubMed ID: 25636915

  • 21. Successful African introduction of a new Group A meningococcal conjugate vaccine: Future challenges and next steps.
    LaForce FM, Djingarey M, Viviani S, Preziosi MP.
    Hum Vaccin Immunother; 2018 May 04; 14(5):1098-1102. PubMed ID: 28968148
    [Abstract] [Full Text] [Related]

  • 22. Population-Level Persistence of Immunity 2 Years After the PsA-TT Mass-Vaccination Campaign in Mali.
    Basta NE, Borrow R, Berthe A, Dembélé AT, Onwuchekwa U, Townsend K, Boukary RM, Mabey L, Findlow H, Bai X, Sow SO.
    Clin Infect Dis; 2015 Nov 15; 61 Suppl 5(Suppl 5):S547-53. PubMed ID: 26553687
    [Abstract] [Full Text] [Related]

  • 23. Persistent low carriage of serogroup A Neisseria meningitidis two years after mass vaccination with the meningococcal conjugate vaccine, MenAfriVac.
    Kristiansen PA, Ba AK, Ouédraogo AS, Sanou I, Ouédraogo R, Sangaré L, Diomandé F, Kandolo D, Saga IM, Misegades L, Clark TA, Préziosi MP, Caugant DA.
    BMC Infect Dis; 2014 Dec 04; 14():663. PubMed ID: 25472422
    [Abstract] [Full Text] [Related]

  • 24. [Study of the immunization coverage determinants of vaccination campaign against meningococcal A meningitis in Burkina Faso].
    Ouatara S, Faye A, Leye MM, Niang K, Tal-Dia A.
    Rev Epidemiol Sante Publique; 2015 Dec 04; 63(6):347-53. PubMed ID: 26547670
    [Abstract] [Full Text] [Related]

  • 25. Serogroup W Meningitis Outbreak at the Subdistrict Level, Burkina Faso, 2012.
    Cibrelus L, Medah I, Koussoubé D, Yélbeogo D, Fernandez K, Lingani C, Djingarey M, Hugonnet S.
    Emerg Infect Dis; 2015 Nov 04; 21(11):2063-6. PubMed ID: 26488128
    [Abstract] [Full Text] [Related]

  • 26. Vaccination information, motivations, and barriers in the context of meningococcal serogroup A conjugate vaccine introduction: A qualitative assessment among caregivers in Burkina Faso, 2018.
    Aksnes BN, Walldorf JA, Nkwenkeu SF, Zoma RL, Mirza I, Tarbangdo F, Fall S, Hien S, Ky C, Kambou L, Diallo AO, Aké FH, Hatcher C, Patel JC, Novak RT, Hyde TB, Medah I, Soeters HM, Jalloh MF.
    Vaccine; 2021 Oct 15; 39(43):6370-6377. PubMed ID: 34579975
    [Abstract] [Full Text] [Related]

  • 27. Neisseria meningitidis serogroup W, Burkina Faso, 2012.
    MacNeil JR, Medah I, Koussoubé D, Novak RT, Cohn AC, Diomandé FV, Yelbeogo D, Kambou JL, Tarbangdo TF, Ouédraogo-Traoré R, Sangaré L, Hatcher C, Vuong J, Mayer LW, Djingarey MH, Clark TA, Messonnier NE.
    Emerg Infect Dis; 2014 Mar 15; 20(3):394-9. PubMed ID: 24571805
    [Abstract] [Full Text] [Related]

  • 28. Serogroup A meningococcal conjugate vaccines: building sustainable and equitable vaccine strategies.
    Sherman AC, Stephens DS.
    Expert Rev Vaccines; 2020 May 15; 19(5):455-463. PubMed ID: 32321332
    [Abstract] [Full Text] [Related]

  • 29. Phenotypic and genotypic characterization of meningococcal carriage and disease isolates in Burkina Faso after mass vaccination with a serogroup a conjugate vaccine.
    Kristiansen PA, Ba AK, Sanou I, Ouédraogo AS, Ouédraogo R, Sangaré L, Diomandé F, Kandolo D, Thomas JD, Clark TA, Laforce M, Caugant DA.
    BMC Infect Dis; 2013 Aug 02; 13():363. PubMed ID: 23914778
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Evaluation of meningococcal meningitis vaccination strategies for the meningitis belt in Africa.
    Miller MA, Wenger J, Rosenstein N, Perkins B.
    Pediatr Infect Dis J; 1999 Dec 02; 18(12):1051-9. PubMed ID: 10608623
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Adverse events following immunization during mass vaccination campaigns at first introduction of a meningococcal A conjugate vaccine in Burkina Faso, 2010.
    Ouandaogo CR, Yaméogo TM, Diomandé FV, Sawadogo C, Ouédraogo B, Ouédraogo-Traoré R, Pezzoli L, Djingarey MH, Mbakuliyemo N, Zuber PL.
    Vaccine; 2012 May 30; 30 Suppl 2():B46-51. PubMed ID: 22230584
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Meningococcal carriage in the African meningitis belt.
    MenAfriCar Consortium.
    Trop Med Int Health; 2013 Aug 30; 18(8):968-78. PubMed ID: 23682910
    [Abstract] [Full Text] [Related]

  • 38. Development and use of a serum bactericidal assay using pooled human complement to assess responses to a meningococcal group A conjugate vaccine in African toddlers.
    Bash MC, Lynn F, Mocca B, Borrow R, Findlow H, Hassan-King M, Preziosi MP, Idoko O, Sow S, Kulkarni P, Laforce FM.
    Clin Vaccine Immunol; 2014 May 30; 21(5):755-61. PubMed ID: 24671551
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 28.